Disadvantaged Subgroups Within the Global Head and Neck Cancer Population: How Can We Optimize Care?
Am Soc Clin Oncol Educ Book
; 42: 1-10, 2022 Apr.
Article
en En
| MEDLINE
| ID: mdl-35439036
ABSTRACT
Within the global head and neck cancer population, there are subgroups of patients with poorer cancer outcomes independent from tumor characteristics. In this article, we review three such groups. The first group comprises patients with nasopharyngeal cancer in low- and middle-income countries where access to high-volume, well-resourced radiotherapy centers is limited. We discuss a recent study that is aiming to improve outcomes through the instigation of a comprehensive radiotherapy quality assurance program. The second group comprises patients with low socioeconomic status in a high-income country who experience substantial financial toxicity, defined as financial hardship for patients due to health care costs. We review causes and consequences of financial toxicity and discuss how it can be mitigated. The third group comprises older patients who may poorly tolerate and not benefit from intensive standard-of-care treatment. We discuss the role of geriatric assessment, particularly in relation to the use of chemotherapy. Through better recognition and understanding of disadvantaged groups within the global head and neck cancer population, we will be better placed to instigate the necessary changes to improve outcomes and quality of life for patients with head and neck cancer.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
Problema de salud:
1_financiamento_saude
Asunto principal:
Neoplasias Nasofaríngeas
/
Neoplasias de Cabeza y Cuello
Aspecto:
Patient_preference
Límite:
Aged
/
Humans
Idioma:
En
Revista:
Am Soc Clin Oncol Educ Book
Año:
2022
Tipo del documento:
Article
País de afiliación:
Australia